Josh Bilenker
Director/Board Member presso SANA BIOTECHNOLOGY, INC.
Patrimonio netto: 200 000 $ in data 31/03/2024
Profilo
Joshua H.
Bilenker was the founder of Loxo Oncology, Inc. (founded in 2013) where he held the title of President, Chief Executive Officer, CFO & Director from 2013 to 2015.
Dr. Bilenker is also the founder of Treeline Biosciences, Inc. Dr. Bilenker's current job is as an Independent Director at Sana Biotechnology, Inc. since 2021.
Dr. Bilenker's former jobs include being a Director at LENSAR, Inc., an Independent Non-Executive Director at ViewRay Technologies, Inc., an Independent Director at Sorrento Tech, Inc. from 2012 to 2015, an Independent Director at ViewRay, Inc. from 2008 to 2017, a Director at BioEnterprise Corp., an Independent Director at T2 Biosystems, Inc. from 2011 to 2017, a Director at National Comprehensive Cancer Network Foundation, an Independent Director at Gossamer Bio, Inc. from 2018 to 2023, a Director at Roka Bioscience, Inc. from 2012 to 2015, an Operating Partner at Aisling Capital LLC from 2006 to 2019, a Medical Officer at US Food & Drug Administration from 2004 to 2006, and a Board Observer at Aragon Pharmaceuticals, Inc. Dr. Bilenker's education includes an undergraduate degree from Princeton University in 1994 and a doctorate degree from The Johns Hopkins University School of Medicine in 1999.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC.
0.01% | 03/04/2023 | 20 000 ( 0.01% ) | 200 000 $ | 31/03/2024 |
GOSSAMER BIO, INC.
-.--% | 12/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Josh Bilenker
| Società | Posizione | Inizio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director/Board Member | 08/01/2021 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Founder | - |
Precedenti posizioni note di Josh Bilenker
| Società | Posizione | Fine |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 08/06/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2021 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Private Equity Investor | 01/12/2019 |
| LOXO ONCOLOGY INC | Chief Executive Officer | 01/02/2019 |
| VIEWRAY, INC. | Director/Board Member | 01/06/2017 |
Formazione di Josh Bilenker
| Princeton University | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| LENSAR, INC. | Health Technology |
| VIEWRAY, INC. | Health Technology |
| T2 BIOSYSTEMS, INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 10 |
|---|---|
Viewray Technologies, Inc.
 Viewray Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH. | Commercial Services |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Finance |
Sorrento Tech, Inc.
 Sorrento Tech, Inc. Medical SpecialtiesHealth Technology Sorrento Tech, Inc., also known as Roka Bio Science, is a private company that specializes in food safety technology. The company is based in Warren, NJ and has subsidiaries in the United States. The company's core technology is the Roka pathogen detection assays, which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to deliver a fully automated, single-protocol assay with reduced enrichment times and superior sensitivity. The company's products include the Atlas® system and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bio Science provides solutions for the beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing industries. Roka Bio Science was founded in 2009 by Paul G. Thomas. | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
BioEnterprise Corp.
 BioEnterprise Corp. Miscellaneous Commercial ServicesCommercial Services BioEnterprise Corp. provides access to capital through both its relationships with venture capital and investment banking firms. It initiates for start up funding, and networking information, recruitment, and emerging support firms, including medical devices companies. The company was founded in 2002 and is headquartered in Cleveland, OH. | Commercial Services |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
| National Comprehensive Cancer Network Foundation | |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Josh Bilenker
